SWOG clinical trial number
CTSU/A021501
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Closed
Phase
Abbreviated Title
Preop Extended Chemo vs. Chemo + Plus Hypofractionated Radiation for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Status Notes
Effective Monday, May 06, 2019 at 4:30 PM ET, Alliance A021501 will be permanently closed to new patient pre-registration (Step 0) as it has met its accrual goal.
Activated
12/15/2016
Participants
ALLIANCE, ECOG-ACRIN, NRG, SWOG
Research committees
Gastrointestinal Cancer
Treatment
5-Fluorouracil
Irinotecan
Leucovorin Calcium
Oxaliplatin
Publication Information Expand/Collapse
Other Clinical Trials
SWOG Clinical Trial Number
S2001
Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects
Research Committee(s)
Gastrointestinal Cancer
Activated
12/04/2020
Accrual
1%
Open
Phase
II
SWOG Clinical Trial Number
CTSU/EA2176
A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
Research Committee(s)
Gastrointestinal Cancer
Activated
10/15/2020
Open
Phase
III
SWOG Clinical Trial Number
CTSU/A021806
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
07/01/2020
Open